EUVIMEDEUVIMED entdecken
Open Access

Non–β-Lactam Antibiotic Use, β-Lactam Allergy, and Surgical Site Infections

Prateek Agarwal, Rohit Prem Kumar, Louise-Marie Oleksiuk, Victoria Crall, Andrej A Petrov, Erin K McCreary, Jennifer Holder-Murray, Yue-Fang Chang, Nitin Agarwal, D Kojo Hamilton, Robert M Friedlander

JAMA Surgery · 2025

DOI: 10.1001/jamasurg.2025.3789 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAMA Surgery, 2025. Verfasst von Prateek Agarwal und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurological Surgery, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania. Hauptthemen laut MEDLINE: Surgical Wound Infection, Drug Hypersensitivity, beta-Lactams, Anti-Bacterial Agents. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Surgical site infections (SSIs) pose significant health and economic burdens. β-lactams are the recommended prophylactic antibiotics for most surgical procedures; however, the association of non–β-lactam antibiotics with SSI incidence is controversial.

Objective

To evaluate the association between reported β-lactam allergy status, β-lactam antibiotics, and SSIs across various surgical specialties. Design, Setting, and Participants This was a retrospective cohort study of a prospectively recorded database. The setting was a quaternary health center. Included in the study were patients who underwent surgery from January 2021 to February 2024. Exposures Study exposures included antibiotic choice and reported β-lactam allergy, with covariates including demographics, comorbidities, and procedure details. Main Outcomes and Measures The primary study outcome was 30- to 90-day SSI incidence.

Results

The study included 49 279 procedures across 10 specialties, with a total of 41 100 patients (mean [SD] age, 61.0 [15.9] years; range, 13-103 years; 21 237 male [51.7%]). Procedures with non–β-lactam antibiotic use had a higher incidence of SSI than procedures with β-lactam antibiotic use (2.2% vs 1.3%; risk ratio [RR], 1.69; 95% CI, 1.28-2.01; P < .001). Procedures in patients with reported β-lactam allergy had a higher incidence of SSI (1.8% vs 1.3%; RR, 1.38; 95% CI, 1.15-1.64; P = .003). These associations were present in logistic regression as well. However, on controlling for covariates and β-lactam allergy, non–β-lactam antibiotic use remained significantly associated with higher SSI incidence (odds ratio [OR], 1.33; 95% CI, 1.00-1.74; P = .04), whereas the association between β-lactam allergy and SSI incidence became nonsignificant (OR, 1.21; 95% CI, 0.97-1.49; P = .09). In subspecialty analysis, only orthopedic surgery retained a significant association between non–β-lactam use and increased SSI (OR, 3.01; 95% CI, 1.41-6.01; P = .003). Conclusions and Relevance This cohort study found that β-lactam prophylaxis was associated with significantly lower SSI rates than non–β-lactam agents, and a reported β-lactam allergy did not independently predict infection risk. Implementation of an allergy-focused stewardship guideline was associated with a marked reduction in non–β-lactam use, underscoring the importance of precise allergy assessment to avoid unnecessary alternative prophylaxis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Surgical Wound InfectionDrug Hypersensitivitybeta-LactamsAnti-Bacterial AgentsAntibiotic ProphylaxisHumansMaleFemaleMiddle AgedRetrospective StudiesAgedAdultIncidenceAged, 80 and overAdolescentYoung Adult

Substanzen

beta-LactamsAnti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Neurological Surgery, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
  • Department of Pharmacy, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
  • Department of Infection Control and Hospital Epidemiology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
  • Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, University of Pittsburgh Medical Center.
  • Department of Medicine, Division of Infectious Diseases, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
  • Department of Surgery, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.

Zitieren

APA

Agarwal, P., Kumar, R. P., Oleksiuk, L. M., Crall, V., Petrov, A. A., McCreary, E. K., Holder-Murray, J., Chang, Y. F., Agarwal, N., Hamilton, D. K., & Friedlander, R. M. (2025). Non–β-Lactam Antibiotic Use, β-Lactam Allergy, and Surgical Site Infections. JAMA Surgery. https://doi.org/10.1001/jamasurg.2025.3789

Vancouver

Agarwal P, Kumar RP, Oleksiuk LM, Crall V, Petrov AA, McCreary EK, et al. Non–β-Lactam Antibiotic Use, β-Lactam Allergy, and Surgical Site Infections. JAMA Surgery. 2025. doi:10.1001/jamasurg.2025.3789

BibTeX
@article{Agarwal2025,
  author = {Agarwal, Prateek and Kumar, Rohit Prem and Oleksiuk, Louise-Marie and Crall, Victoria and Petrov, Andrej A and McCreary, Erin K and Holder-Murray, Jennifer and Chang, Yue-Fang and Agarwal, Nitin and Hamilton, D Kojo and Friedlander, Robert M},
  title = {Non–β-Lactam Antibiotic Use, β-Lactam Allergy, and Surgical Site Infections},
  journal = {JAMA Surgery},
  year = {2025},
  doi = {10.1001/jamasurg.2025.3789}
}
Kostenlos starten →